Integra LifeSciences Holdings (IART) reported second quarter adjusted EPS of $0.45 Wednesday morning, which was in line with analysts' estimates. The company maintained its full year adjusted EPS forecast of 1.88 to $1.94, but lowered its organic revenue growth range to 6.0% to 7.0%, from previous range of 7.0% to 8.5%.
from RTT - Before the Bell http://ift.tt/2u1ntnl
via IFTTT
No comments:
Post a Comment